EPO Patents = 2

Forward Citations = 32

Loading Chart...

1 inventor (with patents filed for the assignee):

Mustapha Haddach (11 out of 34 patents)

11 patents: Sort by Forward Citations

1. 11912706 - Crystal forms of a POL1 inhibitor (2024-02-27),

2. 11866438 - Compositions, uses and methods for making them (2024-01-09),

3. 11623928 - Compositions, uses and methods for making them (2023-04-11),

4. 11618752 - Compositions, uses and methods for making them (2023-04-04),

5. 10975076 - Compositions, uses and methods for making them (2021-04-13),

6. 10745403 - Compositions, uses and methods for making them (2020-08-18),

7. 10590134 - Compositions, uses and methods for making them (2020-03-17),

8. 10442801 - Compositions, uses and methods for making them (2019-10-15),

9. 9951066 - Compositions, uses and methods for making them (2018-04-24),

10. 9758518 - Compositions, uses and methods for making them (2017-09-12),

11. 9512123 - Compositions, uses and methods for making them (2016-12-06),

Company Overview

Pimera, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative solutions for the healthcare sector. The organization focuses on advanced therapeutic modalities, particularly in the areas of gene therapy and regenerative medicine. By leveraging cutting-edge research and technology, Pimera aims to address unmet medical needs and improve patient outcomes through its pioneering approaches in biopharmaceuticals and personalized medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#497 in San Diego, CA

#6,532 in California

#27,490 in US

#51,714 in the World

San Diego, CA, United States of America

Pimera, Inc.

Forward Citations = 32

1 inventor:

Mustapha Haddach (11 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pimera, Inc.. Retrieved from https://idiyas.com/company/pimera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]